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Purpose: The purpose of the study was to compare the effect of limited echocardiography (LE)–guided therapy
to standard management on 28-day mortality, intravenous ﬂuid prescription, and inotropic dosing following
early resuscitation for shock.
Materials and methods: Two hundred twenty critically ill patients with undifferentiated shock froma quaternary
intensive care unit were included in the study. The LE group consisted of 110 consecutive patients prospectively
studied over a 12-monthperiod receiving LE-guidedmanagement. The standardmanagement group consisted of
110 consecutive patients retrospectively studied with shock immediately prior to the LE intervention.
Results: In the LE group, ﬂuid restriction was recommended in 71 (65%) patients and initiation of dobutamine
in 27 (25%). Fluid prescription during the ﬁrst 24 hours was signiﬁcantly lower in LE patients (49 [33-74] vs
66 [42-100] mL/kg, P = .01), whereas 55% more LE patients received dobutamine (22% vs 12%, P = .01). The
LE patients had improved 28-day survival (66% vs 56%, P = .04), a reduction in stage 3 acute kidney injury
(20% vs 39%), and more days alive and free of renal support (28 [9.7-28] vs 25 [5-28], P = .04).
Conclusions: Limited echocardiography–guided management following early resuscitation is associated with
improved survival, less ﬂuid, and increased inotropic prescription. A prospective randomized control trial is
required to verify these results.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Despite a signiﬁcant mortality rate, there exists no standard
management algorithm for patients following initial resuscitation for
shock. The underlying etiology of undifferentiated shock remains
predominantly sepsis; and therefore, the Surviving Sepsis efforts
(www.survivingsepsis.org) are primarily used to guide initial care [1].
The focus of this study is the period after the treating teamhas achieved
the targets recommended in these guidelines, when intravenous ﬂuid
administration has resulted in a central venous pressure (CVP) of 8 to
12 mm Hg and the patient requires ongoing vasopressor support to
achieve a mean arterial pressure of at least 65 mm Hg.
Although intravenous ﬂuid is essential to restore perfusion
in shock, once the circulation has been adequately expanded,ational Sanitorium Association,
Laboratories, 1081 Burrard St,
682 2344; fax:+1 604 806 8346.
Inc. This is an open access article uadditional ﬂuid results in tissue edema, longer mechanical venti-
lation (MV), acute kidney injury (AKI), and an increased risk of
death [2–4]. Currently, there is no uniform diagnostic approach able
to reliably determine which patients will or will not increase organ
perfusion in response to additional ﬂuids [5]. In addition to
intravenous ﬂuids, inotropes are sometimes added as adjunctive
therapy when left ventricular systolic dysfunction is believed to be
the cause of inadequate organ perfusion. A 25% incidence of
inotrope-induced arrhythmia mandates the use of inotrope only
when necessary [1].
Limited echocardiography (LE) is deﬁned in this study as standard
parasternal long- and short-axis, apical 4-chamber, and subcostal
views with color-ﬂow Doppler and without alternate views. Easily
accomplished within 5 to 10 minutes at the bedside, LE provides the
treating team with a real-time recommendation for ﬂuid manage-
ment and the need to add an inotrope [6,7]. Despite the widespread
integration of limited echocardiography into clinical practice, there
are very limited data on clinical outcomes [8]. We hypothesized that
LE-based recommendations for intravenous ﬂuid and inotropes would
improve survival compared to standard management in patients with
undifferentiated vasopressor-dependent shock. We also hypothesizednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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reduction in the incidence of AKI and reduced days spent on MV.
2. Materials and methods
2.1. Patients
This study was performed at a quaternary-level hospital (St Paul’s
Hospital in Vancouver, British Columbia) intensive care unit (ICU)
that is the regional cardiovascular center. The study included 220
patients referred to the critical care service with vasopressor-
dependent shock despite an intravenous ﬂuid challenge achieving a
CVP of at least 8 mm Hg. The intervention arm of the study was
conducted over a 12-month period (January 4 to Dec 31, 2012). One
hundred ten patients in the intervention arm had an LE performed
using a handheld device (V-Scan; GE Healthcare, Pittsburgh, PA), and
110 patients were managed in standard fashion (deﬁned below). All
patients were initially mechanically ventilated. Limited echocardiog-
raphy was performed within 24 hours of admission to the ICU and
within 36 hours of admission to the hospital. Study results and
recommendations from the LE were communicated verbally and in
written format to the treating team during themorning intake rounds.
This study was approved by the Providence Health care research
ethics board, and consent was waived.
2.2. Protocol
Echocardiography was performed by 1 of 3 intensivists with
advanced training (American College of Cardiology Level II) in
echocardiography. In no instances were they also the attending
physician for the patient. Limited echocardiography included the
parasternal long axis to assess aortic and mitral valve function,
parasternal short axis at the level of the papillary muscle insertion to
assess global left ventricular systolic function, the 4-chamber apical
view for left and right ventricular size and function, and the subcostal
view to assess the inferior vena cava (IVC) size and respiratory
variability and for pericardial ﬂuid. In cases with poor parasternal or
apical windows, the equivalent views were obtained from the
subcostal approach. In our institution, the outpatient echocardiogra-
phy laboratory uses “eye-ball” approximation of ventricular function
rather than a calculated value via the Simpson method given the
excellent correlation in these values. We chose to adopt this well-
validated approach [9,10].
Left and right ventricular systolic function was graded as normal,
moderate (left ventricular ejection fraction [LVEF] 30%-45%), or
severe systolic dysfunction (LVEF b30%). The pericardium was
assessed for evidence of effusion or possible tamponade, whereas
the IVC diameter’s ﬂuctuation with respiration was graded as either
less than or greater than 15%. Treatment recommendations were 1 of
4 depending upon the LE: (1) less than 15% ﬂuctuation of the IVC
diameter (dIVC) with respiration and normal left ventricular
function= discontinue ﬂuid administration and continue vasopressors
alone; (2) greater than 15% dIVC and normal left ventricular function=
20 to 40 mL/kg intravenous ﬂuid administration; (3) greater than
15% dIVC and moderate to severe left ventricular dysfunction = 10
to 20 mL/kg intravenous ﬂuid and dobutamine 5 μg/(kg min);
(4) moderate to severe left ventricular systolic dysfunction and a dIVC
less than 15% = dobutamine 5μg/(kg min) and ﬂuid restriction. Right
ventricular dysfunction was deemed present if there was bowing of the
intraventricular septum throughout the cardiac cycle and a right
ventricle at least as large as the left ventricle in the apical 4-chamber
view. Valvular pathologywas noted and graded as per American Society
of Echocardiography guidelines only using color Doppler and observa-
tion of valve motion. If compatible with severe valvular stenosis or
regurgitation, a formal echocardiogram was requisitioned and per-
formed for a compete assessment.One hundred ten consecutive patients admitted prior to January 4,
2012, with non–LE-guided, standard management of shock were
enrolled into this study following informed consent to review records
from the critical care research database. St Paul’s Hospital standard
shock guidelines adhere closely to the 2012 Surviving Sepsis
guidelines [11]. They suggest 20 to 40 mL/kg initial intravenous
ﬂuid and further ﬂuids as appropriate. A central line is placed in the
jugular or subclavian positions, and intravenous ﬂuid is administered
until a CVP of 8 to 12 mm Hg is achieved. Further ﬂuid boluses are at
the discretion of the treating team. Noradrenaline is the suggested
initial vasopressor if the mean arterial pressure remains below 65mm
Hg. Once patients are transferred to the ICU, dobutamine may be
added for a central venous oxygen saturation less than 70% and
evidence of ongoing hypoperfusion (urine output b 0.5mL/[kg h] or an
arterial lactate N 2 mmol/L). This control population was chosen to
avoid bias from the intervention (in a nonrandomized or blinded trial)
and to acquire the most representative population in which to assess
the intervention.
2.3. Statistical analysis
The primary outcome was 28-day mortality. Secondary outcomes
included ﬂuid prescription during the ﬁrst 4 days andmeasurement of
organ dysfunction, calculated as days alive and free of renal
replacement therapy (RRT) or MV [12]. Patients with end-stage
renal failure were excluded from the days alive and free of RRT. All
patients were classiﬁed according to the current Kidney Disease:
Improving Global Outcomes guidelines for AKI based on serum
creatinine (SCr) (www.kdigo.org). An AKI (stage 1)was deﬁned by SCr
rise of at least 26.5 μmol/L within 48 hours or SCr increase of at least
1.5-fold from the baseline reference value. Stage 2 AKIwas deﬁned as a
2.0- to 2.9-fold increase from baseline reference SCr. Stage 3 AKI was
deﬁned as an at least 3-fold increase from baseline reference SCr, or an
increase of 354 μmol/L, or commenced on RRT irrespective of stage of
AKI. The reference SCr is deﬁned as the lowest creatinine value
recorded within 3 months of the event, or from repeat SCr within
24 hours, or estimated from the nadir SCr value if a patient recovers
from AK. Patients with chronic kidney disease at admission
were excluded.
Our primary analysis used Kaplan-Meier estimation of survival
function; univariate analyses was performed using χ2 for categorical
data and either Kruskal-Wallis tests or t tests for continuous data. All
tests were 2-sided. Differences in baseline characteristics were
considered signiﬁcant if P b .05 and were subsequently used in a
Cox proportional hazards model to determine the risk of mortality
associated with LE. Although nonsigniﬁcant, we forced the Acute
Physiology and Chronic Health Evaluation (APACHE) II score as a
covariate in the statistical model. Subgroups according to etiology of
shock were analyzed using stratiﬁed Cox regression and the Breslow
method of ties. All analyses were performed using R (version 2.8.1,
www.R-project.org) and SPSS version 16.0 (SPSS Inc., Chicago, IL)
statistical software packages.
3. Results
A total of 220 patients were included in this study: 110 in the LE
cohort and 110 in the standard management group. All patients were
followed up to 28 days for mortality, with outcome data available for
all patients included in the study. Table 1 describes the baseline LE
patients compared to standard management. As markers of chronic
health, APACHE II, age, and the presence of chronic organ failures
inﬂuence outcome independently of intervention. The LE and
standard management groups did not differ with respect to these
variables. The discharge diagnosis pertaining to the cause of shock
was predominantly vasodilatory (78% LE and 75% standard manage-
ment) followed by cardiac (12% LE and 15% standard management).
Table 1
Patient demographics
Demographics LE (n = 110) Standard (n = 110) P
Age (y) 63 (50-73) 66 (55-75) .27
Gender, n (%) female 44 (40) 32 (30) .10
APACHE II 23 (19-29) 24 (18-29) .73
BMI 28.6 (24-34) 28.2 (25-33) .97
Cause of shock, n (%)
Vasodilatory 86 (78) 83 (75) .38
Cardiac 14 (12) 16 (15) .21
Hemorrhage 3 (3) 5 (5) .45
Mixed 7 (6) 7 (6) .14
Preexisiting conditions, n(%)
CHF (LVEF b 35%) 6 (5) 5 (4) .95
Chronic renal disease 11 (15) 17 (17) .68
Physiology (ICU admission)
Fluid ml/kg prior to ICU 68 (58-76) 65 (55-72) .90
AKI stage 3, n (%) 10 (9) 12 (11) .73
Mean arterial pressure 62 (55-70) 67 (60-73) .003
CVP (mm Hg) 13 (9.0-15) 13 (10-16) .47
Heart rate 110 (92-125) 110 (96-125) .48
Norepinepherine (μg/min) 10 (5.0-16) 12 (6.0-24) .06
Laboratory variables
White blood cell count
(103/mm3)
12 (9.0-20) 11 (7.0-16) .23
Platelet count 176 (120-250) 176 (94-250) .26
PaO2/FIO2 ratio 181 (130-280) 219 (160-270) .15
Creatinine 141 (80-240) 112 (74-250) .18
Bilirubin 13 (7.0-28) 13 (7.0-28) .92
Lactate 1.6 (1.1-3.0) 1.4 (1.1-3.0) .90
pH 7.27 (7.20-7.30) 7.29 (7.20-7.30) .35
Na+ 137 (130-140) 140 (140-140) .39
Urea 10.7 (7.3-20) 10.9 (6.8-18) .76
Hematocrit 0.29 (0.25-0.33) 0.29 (0.26-0.66) .36
Values are reported as median (interquartile range); signiﬁcance = P b .05. BMI
indicates body mass index; CHF, congestive heart failure.
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occult bleeding. No signiﬁcant differences were noted between
groups with respect to cause of shock. In the LE group, during the
ﬁrst day of admission, the lowest mean arterial pressure was slightly
lower than standard management (62 [55-70] mm Hg vs 67 [60-73]
mm Hg in those with standard management). Laboratory values
associated with severity of presentation including arterial pH and
lactate were not different between groups (Table 1).
3.1. LE ﬁndings
In the LE group, 19% of patients had ﬁndings compatible with
signiﬁcant valvular abnormalities (Table 2). None of these required
cardiothoracic procedures to reverse the disease. Twenty-ﬁve percent
of patients had severely depressed LVEF. Diameter of IVCwas less than
15% with respiration in 65% of cases, suggesting an extremely low
probability of augmenting forward ﬂow with additional ﬂuids.Table 2
LE ﬁndings and management suggestions
Findings LE (n =110)
Time (h) to LE from ED admission med (IQR) 11 (7.5-15)
Signiﬁcant valvular pathology, n (%) 14 (19)
Moderate-severe LV failure, n (%) 27 (25)
IVC collapsability
b15%, n (%) 71 (65)
N15%, n (%) 39 (35)
Signiﬁcant pericardial effusion, n (%) 0 (0)
RV dysfunction (moderate to severe), n (%) 34 (30)
Suggested change in management
Restrict ﬂuid, n (%) 71 (65)
Add inotropes, n (%) 27 (25)
IQR indicates interquartile range; LV, left ventricle; RV, right ventricle.Moderate to severe right ventricular dysfunction was observed in
9% of cases.
3.2. LE-based treatment
The most common recommendation (Table 2) was to restrict ﬂuid
administration (65%) followed by the addition of inotropic therapy
(25%). In this cohort, 6 (5%) patients had repeat studies at the request
of the treating team. All of these studies were more than 7 days
following the initial LE.
3.3. Fluid and inotrope prescription
Reﬂecting the 65% recommendation to discontinue ﬂuid admin-
istration in the LE group, ﬂuid administration was signiﬁcantly lower
(P= .04) during the ﬁrst 24 hours of therapy following completion of
early goal-directed therapy (LE vs standard management, 49 [33-74]
vs 66 [42-100] mL/kg). Fluid administration was not signiﬁcantly
different between groups during days 2 to 4 (Table 3) . Urine output in
the LE group was greater in each of the 4 days following admission
(Fig. 1), but this did not reach statistical signiﬁcance. Despite an equal
incidence of known congestive heart failure (Table 1), 22% of patients
received dobutamine in the LE group compared to 12% with standard
management (P = .01).
3.4. Clinical outcomes
Kaplan-Meier 28-day survival analysis favored patients receiving
LE, with a 28-day survival rate of 66% vs 56% (P= .04) in the standard
management group (Fig. 2). Using Cox regression analysis to control
for the unmatched variables in Table 1 (mean arterial pressure) as
well as severity of illness upon presentation (APACHE II), we found
that performing LE was associated with a lower risk of death with a
hazard ratio (HR) of 0.64 (0.41-0.98) (P= .014). Patients treated with
LE also had more days alive and free of renal support (28 [9.7-28] vs
25 [5-28], P = .04) compared to standard management. Limited
echocardiography was also associated with a reduction in the
incidence of any AKI (68%) vs standard management (95%) and
with more grade 3 AKI (20% LE vs 39% standard management)
(Table 4). The LE cohort did have a nonsigniﬁcant trend towards more
days alive and free of MV (20 [3-27] vs 18 [2.0-26], P = .565). As
expected, an increase in APACHE II (HR 1.07 [1.04-1.10], P= .02) was
associated with an increased hazard for mortality (Table 5). We
performed Cox regression stratiﬁed by the cause of shock and found
that the protective effect was similar for all causes, with cardiac and
hemorrhagic causes reaching statistical signiﬁcance (Table 5).
3.5. LE-derived dIVC vs CVP or volume infused prior to ICU admission
We compared the usual clinical measures of volume status (CVP
and volume of ﬂuid previously administered in the emergency
department [ED]) to a dIVC ultrasound-based approach. As shown
in Fig. 3, the receiver operating characteristic for CVP compared to
dIVC is 0.42, whereas that of the volume of ﬂuid administered in theTable 3
Intravenous ﬂuid and dobutamine prescription during days 1 to 4
Therapy LE (n = 110) Standard (n = 110) P
Intravenous ﬂuid day 1 (mL/kg) 49 (33-74) 66 (42-100) .04
Intravenous ﬂuid day 2 (mL/kg) 47 (32-66) 44 (29-59) NS
Intravenous ﬂuid day 3 (mL/kg) 42 (29-51) 34 (25-45) NS
Intravenous ﬂuid day 4 (mL/kg) 36 (26-49) 40 (27-49) NS
Dobutamine, n (%) 24 (22) 14 (12) .01
NS indicates not signiﬁcant.
Fig. 2. Black line = LE-guided therapy; gray line = standard management. Kaplan-
Meier estimates of mortality over 28 days. The rate of mortality was signiﬁcantly higher
in the standard treatment group (P = .04).
Table 4
Fig. 1. Central venous pressure and ﬂuid administered in the ED vs dIVC. A and B,
Receiver operating curves compare CVP and ED ﬂuid administration to a dIVC of greater
than 15%, assuming the dIVC is the true estimate of ﬂuid responsiveness (A). The area
under the CVP curve is 0.42, whereas that of the ED ﬂuid intake is 0.52 (B).
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administered can serve as surrogates for dIVC. Overall, there is no
correlation between CVP and dIVC. Thus, the usual clinical measures
of volume status are generally poor predictors for LE-derived dIVC or
(lack of) volume responsiveness.Survival and days alive and free of life support
Outcomes LE (n = 110) Standard (n = 110) P
28-d survival, n (%) 73 (66) 62 (56) .04
Days alive and free from MV 20 (3.0-26) 17 (2.0-26) .57
Days alive and free of RRT 28 (10-28) 26 (5.0-28) .07
AKI LE (n = 95) Standard (n = 93)
Any AKI, n (%) 65 (68) 88 (95) .001
AKI stage 1, n (%) 32 (34) 34 (37) .34
AKI stage 2, n (%) 14 (15) 18 (19) .57
AKI stage 3, n (%) 19 (20) 36 (39) .013
MV=mechanical ventilation, RRT= renal replacement therapy, AKI= acute kidney injury4. Discussion
The major ﬁnding in this study is that the use of LE to guide
subsequent ﬂuid and inotropic therapy in patients, whose shock has
been initially resuscitated with ﬂuids and noradrenaline, is associated
with decreasedmortality compared to standardmanagement. Limited
echocardiography was also associated with a decrease in initial ﬂuid
prescription and an increase in dobutamine use. The most pro-
nounced therapeutic effect of LE-guided treatment was a reduction in
stage 3 AKI and an increase in days alive and free of RRT.Early aggressive resuscitation of mixed shock with intravenous
volume expansion, vasopressors, and inotropes became widely
adopted following the landmark study of Rivers et al [2] in 2001.
Although securing central venous access and aggressive ﬂuid
administration have become standard of care over the ﬁrst 6 to 12
hours [13], the subacute phase of resuscitation is more elusive.
Administration of intravenous ﬂuids in quantities sufﬁcient to achieve
a CVP of 8 to 12mmHg (13mmHg in the original study [2]) is integral
to early goal-directed therapy. However, after this has been achieved,
CVP is unable to predict an increase in cardiac output or organ
perfusion in response to further ﬂuid [5]. Furthermore, in our study,
we illustrate the poor correlation between traditional means of
volume status, namely, CVP, and markers of volume responsiveness
such as dIVC.Without a standardized method allowing the clinician to
determine whether further ﬂuid prescription will augment perfusion,
there may be a tendency to err on the side of additional bolus ﬂuids
while the patient remains on vasopressors, possibly causing more
harm than beneﬁt [4]. How to introduce and titrate inotropes is
equally problematic. The guideline recommends the use of central
venous oxygen saturation, but it is a poor predictor of cardiac
performance in noncardiogenic causes of shock [14]. Inotropic
therapy is not without signiﬁcant adverse effects, as up to 25% of
patients experience serious tachyarrythmias [1]. The treating team is
therefore faced with 2 questions for their patients with continued
vasopressor-dependent shock. First, will further ﬂuids improve
perfusion; and second, does the patient require additional inotropic
support? Bedside echocardiography is unique in that it can answer
both of these questions immediately and noninvasively..
Fig. 3.Daily urine output. Urine output (inmilliliters per kilogram) is plotted in the 2 groups
over the ﬁrst 4 days following admission. Although a clear trend emerges of increased urine
output in the LE group, the effect is not signiﬁcant (P N .05) at any time point.
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for well over 2 decades [15]. With dramatically improved technology
and integration in training fellowship programs, physician-led acute
bedside or point-of-care echocardiography is now becoming com-
monplace [16]. Noncardiologists can be trained to perform bedside
echocardiography with good accuracy in critically ill patients [17]. In
fact, very basic critical care echocardiography can be taught tomedical
residents with good reliability in less than 12 hours [18]. Both
transthoracic and transesophageal echocardiography can be used in
critically ill patients, and using either method has been shown to alter
management of critically ill patients in a signiﬁcant number of
cases [19,20]. However, whether echocardiography-guided changes
in management modify outcome is not certain. Surprisingly, there is
very little literature that relates echocardiography to clinical out-
comes. There are numerous protocols for bedside echocardiography in
critically ill patients, ranging from a complete study suitable for
outpatient echocardiography to very abbreviated forms [9,10,21]. Our
clinical service decided upon a pragmatic approach to allow 10
minutes to determine right and left ventricular systolic function,
assess volume status using the respiratory variability of IVC diameter,
and screen for pericardial and major valvular disease. Two major
studies examined the correlation between the increase in IVC
diameter (ΔDIVC is the fractional increase in IVC diameter) with
positive pressure ventilation and the likelihood of an increase in
cardiac output in response to further intravenous ﬂuids. Barbier et al
[22] reported that a ΔDIVC of N 18% best deﬁned those who
experienced an increased cardiac output with volume expansion,
whereas Feissel et al [23] found a ΔDIVC of greater than 12% was able
to predict volume responsiveness in their mechanically ventilated
patients. The clinical service deﬁned a high likelihood of volume
responsiveness as a ΔDIVC of greater than or equal to 15%.Table 5
Cox proportional hazards analysis of variables inﬂuencing mortality
HR 95% CI
Variable
LE 0.64⁎ 0.41-0.98
Age 1.01⁎ 1.0-1.02
APACHE II 1.07⁎ 1.04-1.10
Subgroup (stratiﬁed analysis)
Vasodilatory 0.60 0.35-1.03
Cardiac 0.58⁎ 0.34-0.99
Hemorrhagic 0.59⁎ 0.34-0.99
Mixed (vasodilatory and cardiac) 0.61 0.36-1.04
⁎ P b .05.Limited echocardiography in this study found moderate to severe
left ventricular dysfunction in 25% of patients. This may be in fact
lower than previously reported estimates of the incidence of severe
left ventricular hypokinesia in septic shock [24]. The direct estimation
of LVEF by LE was associated with a 55% increase in the use of
dobutamine compared to those treated with standard management.
Although the use of dobutamine titrated to oxygen consumption has
not been of beneﬁt to patients in subacute shock, there has yet to be a
randomized controlled trial using ultrasound quantiﬁcation of LVEF to
initiate dobutamine in vasopressor-dependent shock [25]. It is
interesting to note that, in a systematic review of patients at high
risk of AKI, the most protective intervention was the addition of an
inotrope [26]. We feel our improved results compared to previous
studies examining the addition of inotropes in shock may be
attributable to the improved diagnostic accuracy with ultrasound vs
indirect and time-delayed measures of cardiac performance such as
oxygen consumption.
Limited echocardiography evaluations of our patients resulted in
a recommendation of ﬂuid restriction in the majority of our patients.
This ﬂuid restriction is similar to the ﬁndings of a recent small study
in which superior vena caval respiratory ﬂuctuation using trans-
esophageal echocardiography was compared to CVP-based guide-
lines [27]. In this study, LE led to a 33% reduction in ﬂuid
administration during what may be considered the critical ﬁrst day
of ICU admission. Other investigators have found that conservative
ﬂuid strategies favor survival and decrease time spent on MV in
patients with acute respiratory distress syndrome as well as those
with acute lung injury [3,28]. It is also proposed that high venous
pressures created through excessive ﬂuid administration worsen
renal function acutely and may prevent subsequent recovery
[26,29,30]. Furthermore, in patients with septic shock, it appears
that less volume expansion may be associated with a survival
advantage [4,31]. Taken together with our data, we feel that it is
probable that the ﬂuid limitation as a result of LE, together with
matching inotropic support to those most in need, may be in part
responsible for improvement in both survival and renal function.
This study has several limitations. The major limitation is its
nonrandomized nature. The use of historical controls poses the
unavoidable risk of unappreciated confounders, in particular a
systematic change in management being responsible for differences
in outcome. We strove to identify and compare the major clinical
confounders that are known to inﬂuence organ failure and mortality
in shock. Presenting severity of illness, age, and comorbid conditions
appeared well matched between groups and controls. In addition, we
chose a priori to include all consecutive patients immediately prior to
the intervention to include the most comparable population. With
respect to the ongoing validity of information provided by a single LE
study throughout the patient’s stay, this study was not designed to
answer this question, which would require repeated studies through-
out the period of shock. Lastly, our practice locally is to use ﬂuids and
noradrenaline for early goal-directed therapy in the ED; so no
dobutamine is initiated until the patient arrives in the ICU or admitted
to the service. Although this provided us an opportunity to determine
the prescription of dobutamine through LE performed in (or by) the
ICU, our approach may not be applicable to centers that begin
dobutamine earlier in the resuscitation.
We conclude that LE-guided resuscitation following early resus-
citation for shock is associated with improved 28-day survival. The
most important information derived from the LEwas a combination of
LVEF and Inferior Vena Cava Collapsibility Index (IVC-CI) that
signiﬁcantly inﬂuenced volume and inotropic prescription in this
population. Given no signiﬁcant effect upon duration of MV and a
large (19%) reduction in stage 3 AKI with LE, it is probable that
avoidance of advanced renal failure is one mechanism through which
LE improves survival. A prospective randomized control trial is
required to verify these results.
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